Higher Satisfaction with Once-Weekly Insulin Icodec Compared to Daily Doses in Type 2 Diabetes: ONWARDS Trials Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: A recent analysis from the ONWARDS clinical trials has revealed significant improvements in treatment satisfaction among individuals with Type 2...
Novo Nordisk Gets CDSCO Panel Nod To Import, Market Insulin Icodec to treat diabetes mellitus in adults Dr. Divya Colin2 July 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Once-weekly insulin icodec better than once-daily basal insulin analogues in type 2 diabetes: Study Medha Baranwal2 Feb 2024 10:15 AM ISTKarnataka: A meta-analysis of ONWARDS phase 3 randomized controlled trials (RCTs) revealed that once-weekly insulin icodec led to a higher glycated...
Novo Nordisk Gets CDSCO Panel conditional nod to study Insulin icodec Dr. Divya Colin31 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Weekly insulin icodec as effective as daily degludec for management of type 1 diabetes: ONWARDS 6 trial Dr. Kamal Kant Kohli6 Nov 2023 8:15 PM ISTDenmark: Findings from a phase 3 clinical trial have shown once-weekly insulin icodec to be non-inferior to once-daily degludec in HbA1c reduction at...
Weekly insulin icodec offers better glycemic control than daily insulin glargine U100 in type 2 diabetes Dr. Kamal Kant Kohli14 Sept 2023 9:30 AM ISTUSA: A phase 3a trial showed significantly better glycemic control with once-weekly insulin icodec versus once-daily insulin glargine U100 in patients...
Once-weekly insulin icodec noninferior to once-daily insulin degludec for HbA1c reduction in type 2 diabetes: ONWARDS 3 trial Medha Baranwal27 Jun 2023 10:45 AM ISTDenmark: The ONWARDS 3 randomized clinical trial showed the efficacy of once-weekly insulin icodec treatment in patients with insulin-naive type 2...
Once-weekly insulin icodec better than once-daily insulin glargine for patients with type 2 diabetes: ONWARDS 4 trial Medha Baranwal12 May 2023 12:00 PM ISTBelgium: Once-weekly insulin icodec performed equally well as once-daily insulin glargine U100 for glycemic control, required fewer basal insulin...
Continue CT with 30 ongoing Indian subjects: CDSCO panel tells Novo-Nordisk on Insulin Icodec Dr. Divya Colin15 March 2023 6:00 PM ISTNew Delhi: Based on the safety data of 30 Indian subjects in the global clinical trial of Insulin Icodec, the Subject Expert Committee (SEC)...
Submit safety data of initial 30 subjects : CDSCO Tells Novo-Nordisk On IcoSema and insulin icodec study Dr. Divya Colin28 Sept 2022 6:00 PM ISTNew Delhi: Citing to remove the 'interim analysis' from the said condition, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Blood sugar control: Once weekly novel insulin shows promise in Diabetes Dr. Kamal Kant Kohli23 Sept 2020 5:00 PM ISTThe researchers have found in a randomized, double-blind phase 2 trial that once-weekly treatment with basal insulin icodec had blood sugar lowering...
Novo Nordisk Once-weekly Insulin Icodec Shows Comparable Efficacy To Once-daily Insulin Glargine U100 in Phase 2 trial Ruchika Sharma15 Jun 2020 9:30 AM IST"Novo Nordisk has been at the forefront of insulin innovation for almost 100 years, and we continuously conduct disruptive research that can lead to...
